DeepMind introduced AlphaGenome, a comprehensive AI model designed to predict the effects of small DNA mutations on gene regulation and molecular processes. This marks an advance beyond protein folding, tackling the more complex and multifaceted genomic regulatory landscape. Utilizing extensive training data, AlphaGenome can simulate how DNA changes influence gene expression patterns, accelerating biological insights and potentially improving drug target identification. Early adopters emphasize its power to substitute certain wet lab experiments by computational assessment of genetic variant impacts on gene regulation.